NFKB1 and prostate carcinoma: These results confirm that the observed inhibition of AR-V7 induced NF-κB activation by melatonin in the present investigation is mediated via membrane MT1 receptor, which has been shown by us previously to play an important role in transducing the antiproliferative action of melatonin on prostate cancer cells [23].